腹腔镜肾上腺手术规范专家共识

doi:10.19558/j.cnki.10-1020/r.2021.03.001

摘要
图/表
参考文献
相关文章 (15)

[1] HUGHES S, LYNN J.Surgery of the Adrenal Glands//Surgical Endocrinology.New York,Elsevier Science Publishers,1993: 9.
[2] GAGNER ML, BOLTÉ E.Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med, 1992,327(14):1033.
[3] SMITH CD,WEBER CJ,AMERSON JR.Laparoscopic adrenalectomy: New gold standard. World J Surg, 1999,23(4):389-396.
[4] GERMAIN AK, BRUNAUD L.Surgical management of adrenal tumors. J Visc Surg, 2011,148(4):e250-e261.
[5] HUBENS G, YSEBAERT D, VANEERDEWEG W, et al. Laparoscopic adrenalectomy with the aid of the Aesop 2000 robot. Acta Chir Belg, 1999,99(3):125-127; discussion 127-129.
[6] ECONOMOPOULOS KP, MYLONAS KS, STAMOU AA, et al.Laparoscopic versus robotic adrenalectomy:A comprehensive meta-analysis.Int J Surg, 2017,38:95-104.
[7] BRUNAUD L, AYAV A, ZARNEGAR R, et al. Prospective evaluation of 100 robotic-assisted unilateral adrenalectomies.Surgery, 2008,144(6):995-1001; discussion 1001.
[8] 陈羽,丘少鹏,陈炜.微创外科治疗肾上腺肿瘤进展.中国肿瘤,2007,16(6):227-233.
[9] MIRALLIÉ E, BLANCHARD C, CAILLARD C, et al.Adrenocortical carcinoma: Impact of surgical treatment. Ann Endocrinol (Paris), 2019,80(5/6):308-313.
[10] PERYSINAKIS I, AGGELI C, KALTSAS G, et al.Adrenal-sparing surgery: current concepts on a theme from the past. Hormones (Athens), 2020,19(3):317-327.
[11] NEUMANN H, TSOY U, BANCOS I, et al.Comparison of Pheochromocytoma-specific morbidity and mortality among adults with bilateral pheochromocytomas undergoing total adrenalectomy vs cortical-sparing adrenalectomy. JAMA Netw Open, 2019,2(8):e198898.
[12] 中华医学会内分泌学分会.原发性醛固酮增多症诊断治疗的专家共识.中华内分泌代谢杂志,2020,36(9):727-736.
[13] KOBAYASHI T, IWAI A, TAKAHASHI R, et al.Spontaneous rupture of adrenal pheochromocytoma: review and analysis of prognostic factors. J Surg Oncol, 2005,90(1):31-35.
[14] PACAK K.Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab, 2007,92(11):4069-4079.
[15] PULLERITS J, EIN S,BALFE JW.Anaesthesia for phaeochromocytoma.Can J Anaesth, 1988,35(5):526-534.
[16] KINNEY MA, WARNER MA.Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth, 2002,16(3):359-369.
[17] DUH QY.Evolving surgical management for patients with pheochromocytoma. J Clin Endocrinol Metab, 2001,86(4):1477-1479.
[18] 夏溟,李汉忠,刘广华,等.嗜铬细胞瘤术前准备的临床体会(附286例报告).中华泌尿外科杂志,2004,25(12):816-818.
[19] LENDERS JW, DUH QY, EISENHOFER GA, et al.Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2014,99(6):1915-1942.
[20] 范欣荣,李汉忠,夏溟,等.甲襞微循环监测在嗜铬细胞瘤术前准备中的应用.临床泌尿外科杂志,2006,21(7):519-521,524.
[21] LENDERS JW, EISENHOFER G, MANNELLI M, et al.Phaeochromocytoma. Lancet, 2005,366(9486):665-675.
[22] MADANI A, LEE JA.Surgical approaches to the adrenal gland. Surg Clin North Am, 2019,99(4):773-791.
[23] NIEMAN LK, BILLER BM, FINDLING JW, et al.Treatment of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab, 2015,100(8):2807-2831.
[24] SYWAK M,PASIEKA JL.Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg, 2002.89(12):1587-1593.